Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) - Overview

Stock Report

Spectrum Pharmaceuticals Inc SPPI

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap340.80Mil
52-Wk Range-
Yield %-
ISINUS84763A1088
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201320142015
More ...
Income Statement
Revenue155.85186.83162.56
Operating Income-38.79-31.57-40.73
Net Income-62.13-45.72-50.79
Basic EPS-1.02-0.71-0.78
Avg. Diluted Shares Outstanding616565
Balance Sheet
Current Assets235.19222.47191.32
Non Current Assets263.97267.56229.90
Total Assets499.16490.03421.22
Current Liabilities89.98109.4476.34
Total Liabilities217.55235.48208.36
Total Equity281.61254.55212.86
Cash Flow
Operating Cash Flow-2.09-3.636.74
Capital Expenditure-3.16-0.93-0.22
Free Cash Flow-5.25-4.566.52

In millions, except "Basic EPS". Currency is USD.

Company Profile

Spectrum Pharmaceuticals Inc is a biotechnology company with fully integrated commercial and drug development operations with a primary focus on oncology and hematology.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

212
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)-15.32
EPS Growth (3 year avg)-
Operating Margin % TTM-25.06
Net Margin % TTM-31.24
ROE TTM-21.74
Debt/Equity0.48
Dividends
PreviousLatest
More ...
Declared Datet.b.c.10/12/12
Ex-Divt.b.c.18/12/12
Paidt.b.c.28/12/12
Amnt0.000.15
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.